A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.
Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S.
Clin Cancer Res. 2009 Jun 15;15(12):4165-73. Epub 2009 Jun 9.PMID: 19509150 [PubMed - indexed for MEDLINE]Related articles